Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biomarkers of Kidney Transporters DDI Study
NCT05365451Phase 1Completed
- Sponsor
- Washington State University
- Start
- Apr 2022
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of liquid metformin (Aspargo Labs) and furosemide (4 arms), sponsored by Washington State University. Primary endpoints: Metformin Area Under the Concentration vs. Time Curve, Metformin Maximum Concentration and 3 more. Started Apr 2022; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)furosemide
Beyond the preview
Go deeper on NCT05365451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05365451.